Gene · 6300
Papers1,954
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 1,954
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| P38 kinases mediate NLRP1 inflammasome activation after ribotoxic stress response and virus infection. | J Exp Med | 2023 | 36315050 | PubTator, text mining | PubMed |
| Alcohol and breast cancer. | Pharmacol Rep | 2023 | 36310188 | PubTator, text mining | PubMed |
| TRIM67 drives tumorigenesis in oligodendrogliomas through Rho GTPase-dependent membrane blebbing. | Neuro Oncol | 2023 | 36215168 | PubTator, text mining | PubMed |
| In Vitro Effects of Acitretin on Human Neuronal SH-SY5Y Cells. | Neurochem Res | 2023 | 35987975 | PubTator, text mining | PubMed |
| Scaffold protein MAPK8IP2 expression is a robust prognostic factor in prostate cancer associated with AR signaling activity. | Asian J Androl | 2023 | 35975362 | PubTator, text mining | PubMed |
| ERK1/2-RSK regulation of oestrogen homeostasis. | FEBS J | 2023 | 35176205 | PubTator, text mining | PubMed |
| Under-Representation of Racial Groups in Genomics Studies of Gastroenteropancreatic Neuroendocrine Neoplasms. | Cancer Res Commun | 2022 | 36969744 | PubTator, text mining | PubMed |
| Editorial: Updates on immunity to influenza A virus in humans and animals. | Front Immunol | 2022 | 36643917 | PubTator, text mining | PubMed |
| Metastatic phenotype and immunosuppressive tumour microenvironment in pancreatic ductal adenocarcinoma: Key role of the urokinase plasminogen activator (PLAU). | Front Immunol | 2022 | 36591282 | PubTator, text mining | PubMed |
| Inhibition of PI3 kinase isoform p110α suppresses neuroblastoma growth and induces the reduction of Anaplastic Lymphoma Kinase. | Cell Biosci | 2022 | 36585695 | PubTator, text mining | PubMed |
| Signaling pathways of adipose stem cell-derived exosomes promoting muscle regeneration. | Chin Med J (Engl) | 2022 | 36583914 | PubTator, text mining | PubMed |
| Defining the Potential Targets for Biological Activity of Isoegomaketone Based on Network Pharmacology and Molecular Docking Methods. | Life (Basel) | 2022 | 36556480 | PubTator, text mining | PubMed |
| Protein Kinase Inhibitors as a New Target for Immune System Modulation and Brain Cancer Management. | Int J Mol Sci | 2022 | 36555334 | PubTator, text mining | PubMed |
| Dihydromyricetin ameliorates social isolation-induced anxiety by modulating mitochondrial function, antioxidant enzymes, and BDNF. | Neurobiol Stress | 2022 | 36532369 | PubTator, text mining | PubMed |
| IL-1β enhances cell viability and decreases 5-FU sensitivity in novel colon cancer cell lines derived from African American patients. | Front Oncol | 2022 | 36531053 | PubTator, text mining | PubMed |
| Identification and validation of a prognostic risk-scoring model based on sphingolipid metabolism-associated cluster in colon adenocarcinoma. | Front Endocrinol (Lausanne) | 2022 | 36518255 | PubTator, text mining | PubMed |
| An induced pluripotent stem cell-based model identifies molecular targets of vincristine neurotoxicity. | Dis Model Mech | 2022 | 36518084 | PubTator, text mining | PubMed |
| Brain arteriovenous malformation in hereditary hemorrhagic telangiectasia: Recent advances in cellular and molecular mechanisms. | Front Hum Neurosci | 2022 | 36504622 | PubTator, text mining | PubMed |
| Gemcitabine: An Alternative Treatment for Oxaliplatin-Resistant Colorectal Cancer. | Cancers (Basel) | 2022 | 36497380 | PubTator, text mining | PubMed |
| Biochemical Targets and Molecular Mechanism of Ginsenoside Compound K in Treating Osteoporosis Based on Network Pharmacology. | Int J Mol Sci | 2022 | 36430397 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6300/papers?page=13